# Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides

> **NCT06448676** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 200 (estimated)

## Conditions studied

- Wrinkle

## Interventions

- **DRUG:** Botulinum toxin type A

## Key facts

- **NCT ID:** NCT06448676
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2025-10-01
- **Final completion:** 2025-11-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06448676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06448676, "Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06448676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*